Drug Approvals
🇺🇸 FDA Page 24FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 277–288 of 665 articles
FDA Guidelines Enhance Generic Bioequivalence in Oncology Drugs
FDA Restricts Large-Scale Compounding of Weight Loss Drugs
NSF Announces Fourth Annual Pharma Biotech Conference 2026: Key Insights
SGS Acquires Keystone Bioanalytical: A Game Changer for Drug Development
FDA Clarifies 3-Year Exclusivity Guidance: Key Insights
Industry Groups Push for FDA Guidance Changes on Form 483 Responses
China’s Licensing Boom: A Shift in Global Pharma Pipelines
Johnson & Johnson's Strategic Shift: Layoffs in New Jersey
Opportunities in US Healthcare Amid Pricing Pressures
STAT+: Disagreement Between Patients and Hospitals on AI
Trump's Medical Exam: Implications for the Pharmaceutical Industry
The End of Science as We Know It: Implications for Pharma